Botulinum Toxin Treatment of Notalgia Paresthetica-A Critical Review and Update

Area of Science:

• Neurology
• Dermatology
• Pharmacology

Background:

• Notalgia Paresthetica (NP) is a sensory disorder causing upper back itching and pain.
• Current treatments for NP have limited efficacy.
• Botulinum neurotoxin is being explored as a novel therapeutic option for NP.

Purpose of the Study:

• To critically assess the existing literature on botulinum neurotoxin therapy for Notalgia Paresthetica.
• To evaluate the efficacy and safety of botulinum neurotoxin in treating NP symptoms.
• To identify gaps in current research and propose future study designs.

Main Methods:

• A systematic literature search was conducted using Medline, Google Scholar, and Scopus databases.
• Included studies were published up to December 2025, in English or Spanish, and provided detailed treatment information.
• Eight clinical studies involving 34 patients were analyzed, comparing open-label and blinded trial results.

Main Results:

• Open-label studies using onabotulinumtoxin-A (Botox) reported improvements in pruritus and some in pain.
• A single double-blind, placebo-controlled study using incobotulinumtoxinA (Xeomin) did not show significant improvement.
• Discrepancies between study types suggest potential placebo effects or variations in toxin administration.

Conclusions:

• Botulinum neurotoxin therapy shows potential for managing Notalgia Paresthetica symptoms, particularly pruritus.
• Further high-quality, double-blind, placebo-controlled studies with larger cohorts are necessary to confirm efficacy.
• Standardized protocols and consistent neurotoxin selection are recommended for future research.